Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

Mosby's Drug Reference analisi dell'app per 7 gennaio

Mosby's Drug Reference

Mosby's Drug Reference

  • Unbound Medicine, Inc
  • Google Play Store
  • Gratis
  • Settore Medico
14 Day Free Trial ** Featuring Latest Updates** ** Trusted by Health Care Professionals for Over 30 Years ** ABOUT MOSBY’S DRUG REFERENCE Based on the latest 2022 edition, Mosby’s Drug Reference provides health care professionals with the tools they need to eliminate errors and improve accuracy. Drug monographs feature concise, easy-to-understand information and make finding answers easy with sections on each drug’s action, usage, dosage, interactions, side effects, and more. Download this powerful drug resource to your smartphone or tablet for easy access in the classroom or at the point of care. FEATURES • Detailed monographs for more than 5,000 generic and trade-name drugs • Appendix of recent FDA-approvals • Icons for High Alert and Rarely Used medications • Highlighted Black Box Warnings, safety alerts, and life-threatening side effects • Helpful IV therapy updates • Highlight and make custom notes within entries • Create custom notes and highlights within entries • 150+ abbreviations listed for practical understanding • Unlabeled uses and easily confused drug names • Full Text Search help find medications quickly • “Favorites” for bookmarking important entries FREE 14-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete Mosby's Drug Reference mobile app free for 14 days • After 14 days, your Google Play account will be charged $45.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. •NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period. Authors: Linda Skidmore-Roth, RN, MSN, NP Publisher: Elsevier Powered by: Unbound Medicine Unbound Privacy Policy: www.unboundmedicine.com/privacy Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
Mosby's Drug Reference

Ranking di utilizzo di Mosby's Drug Reference

Il ranking di utilizzo si basa sull'algoritmo di Similarweb che calcola le installazioni correnti e gli utenti attivi su un periodo di 28 giorni.

Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--

Utenti attivi giornalieri

Analizza i modelli di utilizzo degli utenti di Mosby's Drug Reference visualizzando i download di Mosby's Drug Reference e gli utenti attivi giornalieri nel tempo.

Utenti

Analizza i modelli di utilizzo degli utenti di Mosby's Drug Reference visualizzando i download di Mosby's Drug Reference e gli utenti attivi giornalieri nel tempo.

Unlock daily active users
nov7icgen

Mosby's Drug ReferenceStatistiche di ranking nel tempo

Classifica di Utilizzo di Similarweb e Classifica Google Play Store per Mosby's Drug Reference

Rank

Nessun dato disponibile

Mosby's Drug Reference Classifica per paese

Paesi in cui Mosby's Drug Reference ha la posizione più alta nelle sue categorie principali

Nessun dato da visualizzare

Interessi degli utenti e categorie principali

Le categorie principali e le app utilizzate dagli utenti di Mosby's Drug Reference

Categorie principali
Affinità
Le migliori app all'interno della categoria
28%
Clover Spin Rush
Scratch:Lucky to Win
Lucky Clover Rush: Casino Slot
Bless Clover-Slot Jackpot
19%
Frenzy Spin - Happy Jackpot
Golden Card: Scratch & Win
13%
Pusher Carnival Lucky Puzzle
Blackjack Scratch
11%
Davis's Drug Guide for Nurses

Principali concorrenti e app alternative

App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.

VITAS® Healthcare App

VITAS® Healthcare App

VITAS Healthcare Corporation

Prepry - ARDMS & CCI Exam Prep

Prepry - ARDMS & CCI Exam Prep

Imago AI LLC

Nice Healthcare

Nice Healthcare

Nice Healthcare

InstaCured: Affordable Health

InstaCured: Affordable Health

InstaCured Medical Group Inc.

Mosby's Drug Reference VS.

gennaio 7, 2026